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Latent TGFβ binding protein-4 (LTBP4) is a multi-domain glycoprotein, essential for regulating 
the extracellular bioavailability of TGFβ and assembly of elastic fibre proteins, fibrillin-1 and 
tropoelastin. LTBP4 mutations are linked to autosomal recessive cutis laxa type 1C (ARCL1C), 
a rare congenital disease characterised by high mortality and severely disrupted connective 
tissues. Despite the importance of LTBP4, the structure and molecular consequences of 
disease mutations are unknown. Therefore, we analysed the structural and functional 
consequences of three ARCL1C causing point mutations which effect highly conserved 
cysteine residues. Our structural and biophysical data show that the LTBP4 N- and C-terminal 
regions are monomeric in solution and adopt extended conformations with the mutations 
resulting in subtle changes to their conformation. Similar to LTBP1, the N-terminal region 
is relatively inflexible, whereas the C-terminal region is flexible. Interaction studies show that 
one C-terminal mutation slightly decreases binding to fibrillin-1. We also found that the 
LTBP4 C-terminal region directly interacts with tropoelastin which is perturbed by both 
C-terminal ARCL1C mutations, whereas an N-terminal mutation increased binding to 
fibulin-4 but did not affect the interaction with heparan sulphate. Our results suggest that 
LTBP4 mutations contribute to ARCL1C by disrupting the structure and interactions of 
LTBP4 which are essential for elastogenesis in a range of mammalian connective tissues.
Keywords: latent TGFβ binding protein-4, fibrillin, fibulin-4, tropoelastin, small angle X-ray scattering
INTRODUCTION
Latent TGFβ binding protein-4 (LTBP4) is a large secreted multi-domain glycoprotein that is 
associated with fibrillin, the major component of extracellular matrix (ECM) microfibrils, in 
the ECM. Two major isoforms of LTBP4 are expressed in mammalian cells, a long (LTBP4L) 
and short form (LTBP4S; Saharinen et  al., 1998), produced by alternative splicing (Kantola 
et  al., 2010). Both isoforms share similar domain structure, but LTBP4L has an additional 
amino-terminal 4-cysteine domain. The long and short LTBP4 isoforms have overlapping 
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expression in the lung and aorta, whereas, in the skin and 
heart, LTBP4S is the major expressed isoform (Bultmann-Mellin 
et  al., 2015). Moreover, LTBP4S has higher expression in lung 
during late embryonic and postnatal periods (Bultmann-Mellin 
et  al., 2017).
Mutations in both LTBP4 isoforms lead to autosomal recessive 
cutis laxa type 1C (ARCL1C), initially named Urban-Rifkin-
Davis Syndrome, and an ARCL1C-like phenotype is seen in 
LTBP4 deficient mice (Sterner-Kock et  al., 2002; Urban et  al., 
2009; Bultmann-Mellin et  al., 2015). ARCL1C patients share 
similar clinical and pathological features of craniofacial, 
pulmonary, gastrointestinal and genitourinary anomalies 
accompanied with generalised cutis laxa. Both ARCL1C patients 
and LTBP4 deficient mice have high postnatal mortality due 
to respiratory failure caused by severely disrupted pulmonary 
elastic fibre architecture (Urban et  al., 2009; Bultmann-Mellin 
et  al., 2015), indicating a crucial role for LTBP4  in elastic 
fibre assembly. LTBP4 regulates extracellular TGFβ bioavailability 
by covalent interaction with the small latent TGFβ complex 
(Saharinen and Keski-Oja, 2000; Annes et  al., 2004).
However, LTBP4 is primarily involved in the regulation of 
elastic fibre assembly in a TGFβ independent manner (Dabovic 
et al., 2009). LTBP4 modulates elastic fibre assembly by interacting 
with other extracellular partners, such as fibulin-4 (Bultmann-
Mellin et  al., 2015, 2016), fibulin-5 (Noda et  al., 2013) and 
fibrillin-1 (Ono et  al., 2009). The LTBP4 C-terminal region 
binds directly to the N-terminal region of fibrillin-1 (Isogai 
et  al., 2003; Ono et  al., 2009) and this interaction is essential 
for deposition of LTBP4  in the matrix (Ono et  al., 2009; 
Zilberberg et al., 2012). The LTBP4 domain structure (Figure 1A), 
as for other LTBP family members (LTBP1, 2 and 3), is highly 
structurally related to fibrillin. Both LTBPs and fibrillin share 
two types of cysteine-rich domains, the six-cysteine epidermal 
growth factor-like domains (EGF) that form disulphide bonds 
in a conserved 1–3, 2–4 and 5–6 pattern and eight-cysteine 
TGFβ binding protein-like (TB) domains that form disulphide 
bonds in a conserved 1–3, 2–6, 4–7 and 5–8 pattern (Yuan 
et al., 1997; Lack et al., 2003). The LTBPs also share a 4-cysteine 
domain near their N-terminus. LTBP4 has 20 EGF-like domains, 
of which 17 are calcium binding (cbEGF), four TB domains 
and a proline-rich interdomain region.
Here, we  focused on three ARCL1C missense mutations 
that affect highly conserved cysteine residues, p.C1186R 
(Callewaert et  al., 2013) and p.C1286S (Su et  al., 2015) in the 
C-terminal region within the second TB and the 16th cbEGF 
domains, respectively, and p.C274G in the N-terminal hybrid 
domain. A cutis laxa (CL) patient with homozygous LTBP4 
p.C1186R mutations suffered a life-threatening pulmonary defect 
hydronephrosis with generalised skin laxity (Callewaert et  al., 
2013). The p.C1286S mutation was reported in a 14-year-old 
female heterozygous for p.G793Efs*5 (resulting in a premature 
termination codon) and p.C1286S with the clinical and 
pathological characteristics of CL. Skin biopsies show large 
globular elastin aggregates and poor integration into the fibrillin 
microfibrils (Su et  al., 2015). Whereas the p.C1186R mutation 
resulted in severe ARCL1C, the C1286S mutation resulted in 
mild to moderate pulmonary disease (Su et  al., 2015). 
The homozygous point mutation p.C274G was first reported 
in a 4-month male with generalised LTBP4-related CL (Urban 
et  al., 2009) and severe pulmonary emphysema caused by 
severely disrupted elastic fibres (Ritelli et  al., 2019). Our 
hypothesis was that mutations in LTBP4 may result in structural 
changes and altered molecular interactions of LTBP4 to result 
in defective elastic fibre assembly.
To determine whether ARCL1C mutations interfere with 
LTBP4 structure and molecular interactions, we  analysed the 
structure of the LTBP4 N- and C-terminal regions using 
complementary structural and biophysical methods and compared 
its structural features with the ARCL1C mutants. We identified 
tropoelastin as a new interaction partner for LTBP4 and 
investigated the impact of ARCL1C mutations on the interactions 
with heparan sulphate, fibulin-4, tropoelastin and fibrillin-1 
to further understand the role of LTBP4 in elastic fibre assembly 
and disruption in ARCL1C.
MATERIALS AND METHODS
Protein Expression and Purification
Human wild-type and mutant LTBP4S N- and C-terminal 
constructs were purchased as gene strings (residues 29–394 
and 1,114–1,557) and ligated into a modified version of the 
mammalian expression vector pCEP4 (Invitrogen), pCEP-Pu/AC7 
 that contains a C-terminal six-histidine residue tag (6x His-tag). 
The recombinant human wild-type and mutant LTBP4 constructs 
were stably transfected and expressed in Human Embryonic 
Kidney (293)-EBNA cells. The proteins were then purified using 
nickel affinity column (GE Healthcare) followed by size-exclusion 
chromatography on an AKTA purifier FPLC using a Superdex 
200 10/300GL column (GE Healthcare) equilibrated with buffer 
containing 10  mm Tris, 150  mm NaCl and pH 7.4 at a flow 
rate of 0.5  ml/min. Protein identity was confirmed by mass 
spectrometry (MS) and western immunoblotting and 
concentration determined using BCA protein assay (Thermo 
Fisher Scientific). Purified proteins were digested using PNGase-F 
according to the manufacturer’s protocol (New England’s Biolabs). 
The removal of glycans was verified using SDS-PAGE. Full-
length fibulin-5, fibulin-4, fibronectin and tropoelastin 
(SHELdelta26A) were expressed and purified as previously 
described (Martin et  al., 1995; Choudhury et  al., 2009; Cheng 
et al., 2018). Tropoelastin (SHELdelta26A) corresponds to amino 
acid residues 27–724 of GenBank entry AAC98394 isoform 
(Vrhovski et  al., 1997).
Multi-Angle Light Scattering
Purified protein samples (0.5  ml at approximately 0.4–1  mg/
ml) were loaded into a Superdex 200 10/300GL column (GE 
Healthcare) running at a flow rate of 0.5  ml/min using a 
buffer containing 10  mm Tris, 150  mm NaCl and pH 7.4. 
Eluted protein fractions were passed from the column into a 
Wyatt DAWN Heleos II EOS 18 angle laser photometer with 
QELS detector (Wyatt Technologies) connected to an Optilab 
T-rEX refractive index detector. The absolute molar mass, 
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FIGURE 1 | Expression and purification of recombinant latent TGFβ binding protein-4 (LTBP4). (A) Schematic diagram of the domain organisation of full-length 
human LTBP4S with interaction sites indicated and the LTBP4 constructs with 6x-His-tag used in this study. Arrows and asterisks indicate the positions of the 
ARCL1C mutations. (B) (i) Amino acid sequence of the second TB domain in LTBP1-4 with the eight conserved cysteine residues shaded. C1186 is the C7 residue 
(highlighted with an asterisk), involved in an intramolecular disulphide bond. C2 and C6 are involved in the interaction with TGFβ-LAP. (ii) Schematic diagram of a 
representative cbEGF domain with conserved cysteine residues labelled and disulphide bonds illustrated by lines. The position of the substituted cysteine, C1286, 
C5 is indicated by an arrow. (C) SDS-PAGE of the purified LTBP4 N- and C-terminal constructs: NWT, C274G, CWT, C1286S and C1186R under reducing (R) and 
non-reducing (NR) conditions.
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concentration and hydrodynamic radius of the resulting peaks 
were analysed using ASTRA 6.
Sedimentation Velocity Analytical 
Ultracentrifugation
Monomeric protein samples (0.4–1  mg/ml) in the same buffer 
as used in multi-angle light scattering (MALS) were characterised 
by sedimentation velocity AUC using a Beckman XL-A analytical 
ultracentrifuge with an An60Ti 4-hole rotor running at 
45,000 rpm at 20°C. The sedimenting boundary was monitored 
at either 280 or 230  nm for 200 scans. Data were analysed 
by continuous model-based distribution C(s) of Lamm equation 
solutions method using SEDFIT software (Schuck, 2000), and 
the resulting sedimentation coefficients were corrected to standard 
conditions using SEDNTERP software (Philo, 1997).
Circular Dichroism
The purified wild-type and mutant LTBP4 samples, at a 
concentration range of 0.5–1  mg/ml in 10  mm Tris, 150  mm 
NaCl and pH7.4 buffer, were analysed by CD using the far-UV 
spectral region (190–260 nm). The far-UV spectra were recorded 
in millidegrees (mdeg) by a Jasco-J810 spectropolarimeter. 
Measurements were taken every 0.2  mm in a 0.5  cm path 
length cell at 25°C. Ten accumulated scans were recorded, 
averaged and corrected for each sample. The secondary structure 
content was quantitatively analysed by the online tool Dichroweb1 
using CDSSTR and CONTIN algorithms.
Small Angle Light Scattering
In-line SEC-SAXS was performed on purified proteins at a 
concentration range of 1–2  mg/ml in the same buffer used 
for MALS and sedimentation velocity analytical 
ultracentrifugation (SV-AUC). CWT and C1286S small angle 
X-ray scattering (SAXS) data were collected at 1  s intervals 
using 45ul purified protein sample passed through a Superdex 
200 3.2/300 column at beamline BM29, European synchrotron 
radiation facility (Grenoble, France), while SAXS data for NWT, 
C274G and C1186R were collected at B21 at Diamond. SAXS 
data were pre-processed and reduced using in-house software 
at each beamline. For each frame with a consistently similar 
radius of gyration (Rg) across the elution peak, the protein 
scattering intensities were merged. SAXS data were then analysed 
and buffer scattering subtracted from that of the sample using 
ScAtter software.2 The Rg of the protein was estimated by 
Guinier analysis and the intraparticle distance distribution 
function P(r) in real space was evaluated using the Indirect 
Fourier transform (IFT) program GNOM, and particle shapes 
were modelled ab initio using DAMMIN software in slow mode 
(Svergun, 1999). For each construct, 10 ab initio models were 
generated to check for reproducibility and the models were 





The binding between the fibrillin-1 PF3 fragment (residues 
1–722; Rock et  al., 2004) and the LTBP4 C-terminal region 
was analysed in real time using the surface plasmon resonance 
(SPR) ProteOn system at 25°C. Fibrillin-1 was diluted in 10 mm 
HEPES, 150  mm NaCl and pH 7.4 supplemented with 0.005% 
(v/v) Tween-20 and then injected at serial dilutions from 
100–0 nm over a constant concentration of immobilised LTBP4 
C-terminal region on amine coupling GLC sensor chip using 
the manufacturer’s instructions (Bio-Rad). All binding 
experiments for each LTBP4 construct were performed at least 
two times. The sensor chip surface was regenerated using 
10  mm glycine at pH 2.5. Equilibrium analysis was used to 
determine kinetic parameters.
Biolayer Interferometry
Binding studies were performed on an OctetRED96 system 
(ForteBio) using biolayer interferometry (BLI). Streptavidin 
biosensors were hydrated in 10  mm HEPES, 150 NaCl and 
pH 7.4, 0.005% (v/v) Tween-20 for 10  min then loaded 
with biotinylated ligand at constant concentration. The loaded 
biosensors were incubated with serial dilutions of analyte 
in the same buffer used for hydration. The biosensors were 
regenerated using 10 mm glycine at pH 2.5. The background 
response was subtracted from all binding sensorgrams and 
all experiments performed in solid black 96 well plates at 
25°C with an agitation speed of 1,000  rpm and repeated 
at least twice. The binding kinetics were analysed using 
Octet software version 7 (ForteBio). The goodness of binding 
data fitting was assessed by χ2 and R2 values. Biotinylated 
human long chain heparan sulphate was kindly provided 
by the Biomolecular analysis facility in the University 
of Manchester.
RESULTS
Expression and Purification of the Human 
LTBP4 N- and C-terminal Regions
To structurally characterise the LTBP4 N- and C-terminal 
regions, HEK293-EBNA cells stably expressing the wild-type 
LTBP4 N- (NWT) and C-terminal regions (CWT) and ARCL1C 
mutants (C274G, C1186R and C1286S) were generated 
(Figures  1A,B). The LTBP4 proteins were purified using 
nickel affinity followed by size-exclusion chromatography 
(SEC; Supplementary Figure S1) with similar elution volumes 
for CWT and mutants and NWT and C274G mutant. To 
determine whether the loss of a cysteine residue resulted in 
aberrant dimerisation for the mutants, samples were analysed 
using non-reducing and reducing SDS-PAGE. Only monomeric 
species were observed for both the wild type and mutants 
with the same shift upon reduction indicating that the free 
cysteine residue in the mutants does not result in dimerisation 
or gross perturbation of folding (Figure 1C). For the N-terminal 
samples, the main species appeared slightly larger than the 
sequence predicted size (NWT 40  kDa), whereas for the 
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C-terminal samples, they were closer to their sequence 
predicted size (CWT 57  kDa). Full-length LTBP4S has six 
putative N-glycosylation sites based on sequence but NetNGlyc 
server prediction suggests only four of these are utilised 
(Gupta and Brunak, 2002), with the C-terminal construct 
predicted to contain one N-linked glycan and the N-terminal 
construct three N-linked glycans. The presence of N-linked 
sugars was verified experimentally using PNGase-F treatment 
which resulted in a lower molecular weight for all LTBP4 
constructs, but with a larger shift in size apparent for the 
N-terminal constructs (Supplementary Figure S2) suggesting 
more glycosylation in the N-terminal region consistent with 
the prediction.
The C-terminal Region of LTBP4 Is 
Elongated and Monomeric
Our recent study on human LTBP1 demonstrated that the 
N-terminal region oligomerises into dimers and higher-ordered 
species in a calcium-dependent manner (Troilo et  al., 2016). 
MALS in combination with SEC and SV-AUC was used to 
determine the size, oligomeric state and hydrodynamic properties 
of the LTBP4 constructs and ARCL1C causing mutants. 
SEC-MALS data showed a single peak for all constructs with 
mass of 47 kDa and 51 kDa for NWT and C274G, respectively, 
and mass of 58  kDa for CWT, C1186R and C1286S indicating 
that they are all monomeric in solution (Figure  2A). The 
hydrodynamic radius was 4.7  nm for both CWT and C1286S 
and 5.0  nm for C1186R (Table  1).
The AUC data confirmed that constructs were monomeric, 
but the AUC profile for C1286S had a small shoulder and 
the profile for C274G small amounts of higher sedimenting 
species indicating an increased tendency to form higher-
ordered species (Figure 2B). CWT sediments at 4.05 Svedberg 
(S20W) and NWT sediments at 3.25 S20W both with frictional 
ratios of 1.4 higher than that expected for a globular protein 
suggesting a moderate elongation of these regions. However, 
the C274G mutant sedimented faster than the wild type 
counterpart (3.61 S20W) with lower frictional ratios (1.33) 
indicative of a more compact structure. In contrast, the 
C-terminal mutants had similar hydrodynamic properties to 
the wild-type protein.
ARCL1C Mutation Alters the Secondary 
Structure of the LTBP4 C-terminal Region
To gain more information on the structure of the LTBP4 
C-terminal region, we  performed circular dichroism (CD). 
Secondary structure was analysed using far UV-CD which 
showed a negative maximum at 205 nm for NWT and 209 nm 
for CWT, characteristic of a high content of β-sheet and 
unordered regions (Figure  2C). The C1286S substitution had 
little impact on the far UV-CD spectra with a shift of 3  nm 
in the position of the negative maxima, whereas a change was 
observed for C1186R, resulting in a shift of 6  nm in the 
position of the negative peak, suggestive of a more unordered 
structure (Figure  2Ci). Using the online tool Dichroweb, the 
secondary structure content was quantitatively analysed and 
summarised. The estimated secondary content for both NWT 
and C274G was similar. For CWT, the estimated α-helical 
content was lower (6.35%), whereas there was a higher proportion 
of β-sheet (32.2%) and unordered regions (61.4%), consistent 
with the expected secondary structure of cbEGF/TB domains. 
The C1186R mutant had a decrease in β-sheet content to 26.6% 
and an increase in unordered structure to 64%. These data 
indicate that the C1186R mutation alters the secondary structure 
of the LTBP4 C-terminal region, possibly resulting in a less 
stable protein.
The LTBP4 C-terminal Region Has an 
Elongated and Flexible Nanostructure
To obtain more detailed structural information, SAXS was 
performed. SAXS data were collected directly from SEC eluates 
to ensure the monodispersity of LTBP4  in solution. The 1D 
scattering intensity data of each construct are plotted as a 
function of q (Figure  3A). DATCMP was used to compare 
the wild-type scattering data to each of the mutants which 
calculated p values below 2.5 e-83 indicating that the data are 
statistically significantly different (Franke et  al., 2015). Guinier 
plots were used for sample quality assessment and determination 
of the radius of gyration (Rg) which showed linearity in the 
Guinier region indicating that no aggregation was present 
(Figure 3C). The Rg was similar for CWT and C1286S (3.9 nm 
and 4.0  nm, respectively), whereas the Rg for C1186R was 
slightly larger (4.2  nm).
The flexibility of the LTBP4 C-terminal region was assessed 
and the normalised Kratky plots show a single peak, with 
maxima slightly deviating from the expected position for a 
globular protein, indicating that this region has an elongated 
structure with some flexibility rather than a compact, globular 
conformation (Supplementary Figure S3). The distance 
distribution function P(r), shown in Figure 3B, is also consistent 
with an extended conformation for the LTBP4 C-terminal 
region. The maximum dimension was 18.0  nm, 18.0  nm and 
18.7  nm for CWT, C1286S and C1186R, respectively. Ab initio 
bead models of the wild type and mutants were generated 
using DAMMIN (Figure 3D). The ab initio models are consistent 
with an elongated conformation but with differences between 
CWT and mutant constructs. The average end-to-end distance 
of the WT models was 16.0  nm, whereas the mutants were 
more extended (C1186R average end-to-end distance = 17.8 nm 
and C1286S average end-to-end distance  =  17.2  nm). The 
structural parameters obtained from the experimental data are 
summarised in Table  1.
For NWT and C274G, the Rg was 3.6 and 3.5 nm, respectively. 
The obtained distance distribution functions P(r) shown in 
Figure  3B, also suggests an extended conformation with 
maximum dimension of 18  nm for the NWT and 15.7  nm 
for the C274G mutant. The scattering intensity at higher angles 
was insufficient for NWT to perform further data analysis so 
the data for C274G were analysed where ab initio models 
confirmed the elongated structure (Figure  3E). The flexibility 
of the N-terminal region was assessed, the Porod-Debye plot 
plateaued at high q range, indicating that this region is not 
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FIGURE 2 | Hydrodynamic properties and secondary structural characterisation of LTBP4. (A) SEC-MALS chromatograms in which the differential refractive index 
(solid lines) and molecular weight (dashed lines) are plotted as a function of elution volume (ml). The colours are purple (CWT), gold (C1186R), green (C1286S), blue 
(Continued)
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flexible (Supplementary Figure S3). The normalised Kratky 
plot displayed single peak with maxima slightly deviating from 
globularity point, indicating that this region is asymmetric 
and elongated (Supplementary Figure S3).
ARCL1C Mutation Reduces Binding to 
Fibrillin-1
LTBP4 binds to fibrillin-1 as has been previously shown 
by solid and solution phase binding studies (Isogai et  al., 
2003; Ono et  al., 2009). These studies demonstrated that 
binding was via the TB3, EGF3 and cbEGF17 domains in 
LTBP4 (domains indicated in Figure  1A). The LTBP4-
fibrillin-1 interaction is essential for matrix assembly and 
incorporation of LTBP4 (Ono et  al., 2009; Zilberberg et  al., 
2012) so ARCL1C causing mutations could interfere with 
this important interaction. Therefore, to investigate the impact 
of ARCL1C mutations on the interaction with fibrillin-1, 
SPR binding analysis was performed. An N-terminal region 
of fibrillin-1 [PF3 fragment as previously described (Rock 
et  al., 2004)] encompassing the LTBP4 binding site was 
used. Fibrillin-1 was injected at different concentrations over 
immobilised LTBP4 C-terminal constructs. The kinetic analysis 
demonstrated that fibrillin-1 strongly interacted with both 
CWT and mutants with low nanomolar affinity (KD). The 
calculated binding affinities for fibrillin-1 to C WT and 
C1286S were equivalent (15.81 and 12.23  nm, respectively), 
indicating that C1286S substitution did not affect this 
interaction (Figure  4), whereas the C1186R mutant had a 
slightly weaker binding affinity with a KD of 40.22  nm, 
indicating that C1186R substitution slightly interfered with 
the fibrillin-1 interaction. Moreover, these data suggest that 
the second TB domain in LTBP4 where residue C1186 is 
located might be  involved in this interaction or that the 
conformational change induced by the mutation may have 
longer-range effects.
The C-terminal Region of LTBP4 Directly 
Interacts With Tropoelastin Which Is 
Perturbed by ARCL1C Mutation
A previous study showed that LTBP4 knockdown prevented 
elastin deposition in human dermal fibroblasts and LTBP4 has 
also been shown to interact with tropoelastin indirectly via 
fibulin-5 (Noda et al., 2013). We wanted to test whether LTBP4 
might interact directly with tropoelastin. Binding studies using 
OctetRED96 BLI were performed using N- and C-terminal 
constructs of LTBP4 to determine if either region binds to 
tropoelastin. The sensorgrams for the N-terminal region showed 
no binding response to immobilised tropoelastin (data not 
shown), whereas the C-terminal region bound to tropoelastin. 
The kinetics of the interaction between CWT and full-length 
tropoelastin were studied by incubating immobilised tropoelastin 
with increasing concentrations of CWT (Figure 5). The binding 
analysis demonstrated that CWT binds to tropoelastin with 
binding affinity of 57  nm. The effect of ARCL1C mutations 
on this interaction was then investigated. Both mutants C1286S 
and C1186R showed weaker binding affinity to tropoelastin 
with a KD of 151.1 and 154.1  nm, respectively. Although the 
steady state analysis for both mutants resulted in a similar 
dissociation constant for binding to tropoelastin, the kinetic 
analysis demonstrated a highly biphasic association and slower 
dissociation steps for C1186R binding to tropoelastin (Figure 5). 
These data indicate that the C1186R mutation interferes with 
tropoelastin binding more than the C1286S mutation. We further 
confirmed the interaction between the C-terminal region of 
LTBP4 and tropoelastin by performing binding studies in the 
opposite orientation, immobilising the LTBP4 C-terminal 
constructs and using tropoelastin as the analyte 
(Supplementary Figure S4).
The Effect of ARCL1C Causing Point 
Mutation on Binding to Fibulin-4
LTBP4 interacts with fibulin-4 to support elastogenesis where 
both LTBP4 long and short isoforms bind to fibulin-4 via the 
N-terminal region (Bultmann-Mellin et  al., 2015). To test 
whether the interaction between the N-terminal region and 
fibulin-4 is affected by the ARCL1C mutation, we  performed 
FIGURE 2 | (NWT) and orange (C274G) and this colour scheme is used in all figures. All constructs are monomeric in solution with mass of 58 kDa for the LTBP4 
C-terminal constructs (i), and 47 and 51 kDa for the NWT and C274G constructs (ii), respectively. (B) Sedimentation velocity profiles from AUC for the (i) C-terminal 
and (ii) N-terminal LTBP4 constructs. (C) The far-UV-CD spectra in the 260–190 nm range for the wild type and mutant LTBP4 (i) C-terminal and (ii) N-terminal 
constructs. CD data show that the spectra have a negative maxima characteristic of proteins with a high β-sheet content and unordered conformation. The C1286S 
substitution had little impact on the CD spectra, whereas a more pronounced difference was observed for C1186R. Ten scans were recorded for each sample. The 
table summarises the secondary structure content of the wild-type and mutant constructs.
TABLE 1 | Experimental hydrodynamic results for LTBP4 C-terminal constructs.
Hydrodynamic 
properties
NWT C274G CWT C1286S C1186R
Molecular mass (kDa)a 47 51 58 58 58
Hydrodynamic radius Rh 
(nm)a
ND ND 4.7 4.7 5.0
Sedimentation coefficient 
(Sw)b
3.15 3.54 4.12 4.24 3.82
Sedimentation coefficient 
(Sw,20)b
3.25 3.61 4.05 4.16 3.75
Frictional ratiob 1.40 1.33 1.39 1.31 1.49
Rh (nm)b 3.20 3.14 3.70 3.61 3.83
Radius of gyration Rg (nm)c 3.6 3.5 3.9 4.0 4.2
Maximum dimension Dmax 
(nm)c
18.0 15.7 18.0 18.0 18.7
aMulti-Angle Light Scattering (MALS).
bSedimentation Velocity Analytical Ultracentrifugation (SV-AUC).
cSmall-Angle X-ray Scattering (SAXS).
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kinetic analysis using BLI. As shown in Figure  6, both NWT 
and C274G bound to immobilised full-length fibulin-4. 
Interestingly, C274G bound to fibulin-4 with a KD of 177.3 nm 
compared to a KD of 1,294  nm for NWT which is a 7-fold 
increase in binding affinity. NWT had faster association and 
dissociation steps compared to C274G (Figure  6A) suggesting 








FIGURE 3 | Structural characterisation of LTBP4 N- and C-terminal regions using small angle X-ray scattering. (A) The experimental 1D scattering intensity I plotted 
as a function of q for (i) CWT, C1286S and C1186R, and (ii) NWT and C274G constructs used for analysis and modelling. (B) The IFT of I vs. q using GNOM, P(r) vs. 
r for wild type and mutants indicate the maximum dimensions in real space. (C) Guinier plot of the low q region for the (i) CWT, C1286S and C1186R and (ii) NWT 
and C274G showing linearity. (D) Five example ab initio models generated by DAMMIN are shown each for CWT (purple), C1286S (green) and C1186R (gold) and 
(E) C274G (orange). Models are shown to the same scale and the average end-to-end length is indicated for each construct.
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The N-terminal Region Does Not Bind to 
Fibronectin but Interacts With Heparan 
Sulphate
Fibronectin directs the assembly and deposition of many ECM 
proteins. LTBP4 deposition is thought to be  mediated via an 
interaction between its N-terminal region and fibronectin. An 
interaction between the LTBP4 N-terminal region and plasma 
fibronectin has previously been observed using solid phase 
binding assays and deletion of the N-terminal region prevented 
interaction with fibronectin (Kantola et  al., 2008). To our 
knowledge, no previous studies have examined this interaction 
using real-time binding methods. To determine whether NWT 
was able to bind fibronectin, we  performed binding studies 
using BLI. However, no binding was detected between 
immobilised NWT and full-length fibronectin (data not shown).
Heparan sulphate (HS) has been reported to mediate binding 
between LTBP1 and fibronectin (Chen et  al., 2007) as no 




FIGURE 4 | Surface plasmon resonance analysis of the fibrillin-1 PF3 construct binding to LTBP4. (A) CWT, (B) C1286S, and (C) C1186R. LTBP4 was immobilised 
on the sensor chip (GLC) using amine coupling and purified fibrillin-1 (PF3) was injected as analyte at different concentrations (100–3.1 nm) over the immobilised 
LTBP4. The binding affinity was determined by steady state with equilibrium response plotted against fibrillin-1 concentration as shown in panel (ii) for all constructs. 
All experiments were performed in at least duplicate and representative curves shown.
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FIGURE 5 | Biolayer interferometry (BLI) analysis of LTBP4CT binding to full-length tropoelastin. OctetRED analysis shows that LTBP4 (A) CWT, (B) C1286S and 
(C) C1186R at different concentrations (375–23.4 nm) directly bind to immobilised full-length tropoelastin. The binding affinity was determined by steady state 
analysis (equilibrium) plotted against (A) (ii) CWT, (B) (ii) C1286S and (C) (ii) C1186R concentration. All experiments were performed in at least duplicate and 
averaged KD in nm are presented. Error bars represent standard deviation.
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Therefore, we  hypothesised that HS might also mediate the 
interaction between LTBP4 and fibronectin. The importance 
of heparin/heparan sulphate (HS) interaction in mediating 
cell adhesion has been previously studied (Bax et  al., 2007) 
and using heparin affinity chromatography, an interaction 
between the LTBP4 N-terminal region and heparin has 
previously been demonstrated (Kantola et  al., 2008). To 
determine the kinetics of a HS-LTBP4 interaction and whether 
the ARCL1C mutation interferes with this interaction, 
we  examined binding using BLI. HS was immobilised then 
incubated with NWT and the sensorgrams show that NWT 
interacts with HS with high affinity (KD = 53.4 nm; Figure 7A). 
The mutant LTBP4 N-terminal region also binds to HS with 
similar affinity KD  =  52.6  nm (Figure  7B).
DISCUSSION
LTBP4 is important for the correct formation of an intact elastic 
fibre network with mutations resulting in ARCL1C, confirming 
its biological significance in elastogenesis (Urban et  al., 2009). 
In our study, we  have provided structural and functional 
information on the LTBP4 N- and C-terminal regions and the 
effect of ARCL1C mutations. Both N- and C-terminal regions 
were monomeric in solution but the N-terminal region had a 
tendency to form higher-ordered species. This is consistent with 
our previous study on LTBP1, where the LTBP1 terminal regions 
were also monomeric but the LTBP1 N-terminal region readily 
multimerised in the presence of calcium (Troilo et  al., 2016). 
Biophysical data show that the N- and C-terminal regions were 
elongated; however, the incorporation of a C274G mutation in 
the hybrid domain induced a more compact conformation. This 
finding is consistent with a previous study on substitutions 
occurring in the hybrid domain of fibrillin-1 that resulted in 
the production of more compact proteins compared with the 
wild type (Mellody et  al., 2006).
Small angle X-ray scattering data showed that the N-terminal 
region had an elongated inflexible conformation. This is consistent 
with our recent study on the N-terminal region of LTBP4 
homolog, LTBP1, which also adopts an elongated and inflexible 
conformation (Troilo et  al., 2016). The C-terminal region was 
also elongated with some flexibility. This finding is consistent 
Ai Aii
Bi Bii
FIGURE 6 | The impact of ARCL1C causing point mutation on LTBP4 N-terminal interaction with fibulin-4. Binding studies using BLI were performed using 
OctetRED analysis. Representative Octet sensorgrams showing both (A) (i) NWT and (B) (i) C274G at a range of concentrations (1000–62.5 nm) bind to immobilised 
fibulin-4. The binding affinity KD was determined by steady state (equilibrium) for (A) (ii) the wild type and (B) (ii) C274G. All experiments were performed in at least 
duplicate and representative results are shown.
Alanazi et al. LTBP4 perturbation by ARCL1C mutations
Frontiers in Genetics | www.frontiersin.org 12 September 2021 | Volume 12 | Article 706662
with our recent study on the C-terminal region of LTBP1 
which also adopts an elongated and flexible conformation 
(Troilo et  al., 2016). The secondary structure was consistent 
with TB and cbEGF domain structures, which are mainly 
composed of β-sheets and small amount of α-helix (Rao et  al., 
1995). The C1286S mutation resulted in a slight increase in 
the β-sheet content, while the C1186R mutant resulted in a 
lower β-sheet and higher-unordered structure content. Together, 
our structural data suggest that the substitution of highly 
conserved cysteines within the hybrid, TB or cbEGF domains, 
impacts the conformation of LTBP4.
The observed structural differences caused by the mutations 
led us to hypothesise that these mutations might also interfere 
with LTBP4 molecular interactions with extracellular proteins. 
Our SPR binding studies demonstrate that the CWT and 
C1286S mutant showed similar binding affinities to fibrillin-1, 
indicating that the substitution in domain cbEGF16 had little 
impact on fibrillin-1 binding. Conversely, the C1186R mutation 
resulted in a slight reduction in the binding to fibrillin-1, 
indicating that this substitution in the second TB domain might 
interfere with fibrillin-1 binding which could suggest that this 
domain contributes to the interaction with fibrillin-1 or the 
structural changes caused by this mutation effect binding. It 
has been demonstrated that fibrillin-1 is required for LTBP4 
deposition (Ono et al., 2009) and so perturbing this interaction 
may result in altered LTBP4 deposition in the matrix.
Our wild-type LTBP4 N-terminal region bound to fibulin-4 
with a KD of 1,294 nm using BLI. This interaction has previously 
A
B
FIGURE 7 | Analysis of LTBP4 N-terminal interaction with fibronectin and HS using BLI. OctetRED sensorgrams showing both (A) the wild type and (B) mutant 
N-terminal region at a range of concentrations (150–9.37 nm) bind to immobilised heparin. The binding affinity KD was 52.6 nm for the wild type and 53.4 nm for the 
mutant, determined by fitting to a 1:1 Langmuir binding model (red curves). All experiments were performed in at least duplicate and representative results are 
shown.
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been analysed using SPR with much higher affinity of 15.4 nm 
but using a much smaller construct consisting only of the 
first two domains of LTBP4S (the 4-cysteine and EGF domains; 
Bultmann-Mellin et  al., 2015). It may be  that the additional 
domains present in our constructs occlude the fibulin-4 binding 
site. However, the C274G construct bound to fibulin-4 with 
higher affinity (KD = 177.3 nm) suggesting that the conformational 
change induced by the mutation may result in increased 
accessibility of the fibulin-4 binding site. The LTBP4 interaction 
with fibulin-4 is vital for fibulin-4-elastin deposition into 
microfibril scaffolds (Bultmann-Mellin et  al., 2015) and 
perturbation of this interaction would likely impact 
on elastogenesis.
Using BLI binding assays, we show that the LTBP4 C-terminal 
region but not the N-terminal region interacts with tropoelastin 
with both C1186R and C1286S mutations slightly impacting on 
tropoelastin binding. A previous study was not able to detect 
an interaction between full-length LTBP4S and tropoelastin using 
solid phase assays (Noda et  al., 2013). However, recently full-
length LTBP4L has been shown to adopt a compact conformation 
that becomes more open and extended after exposure to fibulin-4 
(Kumra et  al., 2019). Therefore, the tropoelastin binding site in 
full-length LTBP4 might be  hidden prior to interaction with 
fibulin-4, whereas in our shortened LTBP4 construct, the binding 
site for tropoelastin might be accessible. Noda et al. also showed 
that fibulin-5 mediates an interaction between LTBP4 and 
tropoelastin (Noda et  al., 2013), it is possible that fibulin-5 
could also induce a conformational change in LTBP4 exposing 
a cryptic tropoelastin binding site. Elastic fibre formation might 
require both indirect and direct molecular interactions between 
LTBP4 and tropoelastin. This is consistent with previous studies 
that observed different elastic fibre ultrastructural anomalies in 
patients with either fibulin-5 or LTBP4 mutations. Both patients 
showed globular elastin deposits in skin that were poorly integrated 
into microfibrils, but the LTBP4 mutations resulted in larger 
elastin deposits and less uniform elastic fibres than fibulin-5 
mutations (Callewaert et al., 2013). These findings are consistent 
with knockdown studies where in the absence of fibulin-5, LTBP4 
was still incorporated into a fibrillar matrix (Noda et  al., 2013).
LTBP4 has been suggested to interact with plasma fibronectin 
via the N-terminal region using solid phase binding methods 
(Kantola et al., 2008). However, we could not detect an interaction 
between purified cellular fibronectin and LTBP4 using BLI. 
Immunolocalisation studies have demonstrated that LTBP4 
colocalises initially with fibronectin but then it deposits into 
the matrix in a fibronectin independent manner and localises 
with fibrillin-1 (Kantola et  al., 2008). Indicating that fibronectin 
might be  required for the initial matrix deposition of LTBP4 
but not in matured tissue. Our finding is consistent with a 
previous study where LTBP1 interacts indirectly with fibronectin 
and through direct interaction with heparan sulphate (Chen 
et  al., 2007). Using heparin affinity chromatography, LTBP4 has 
been shown to directly interact with heparin (Kantola et  al., 
2008). Our real-time binding studies confirmed a direct interaction 
between LTBP4 and heparan sulphate. It has been suggested 
that the direct interaction of LTBP4 with heparan sulphate is 
important for its matrix deposition (Kantola et  al., 2008).
Although for the C-terminal mutations only subtle effects 
were observed, there was more perturbation of the C1186R 
mutation than the C1286S mutation. The difference in effect 
might be  linked to the residue position and type of amino 
acid substitution. C1186R disrupts the C4-C7 disulphide bond 
involved in stabilising intramolecular folding of the second 
TB domain, whereas the cysteine residues involved in disulphide 
bonding to LAP are C2 and C6 (Lack et  al., 2003). There is 
an important hydrophobic area between C6 and C7 responsible 
for binding of TGFβ-LAP (Saharinen and Keski-Oja, 2000) so 
the C7 substitution might disturb this area. While the C1186S 
mutation disrupts the C5-C6 disulphide bridge in the 16th 
cbEGF domain, the disulphide bridges in the cbEGFs of fibrillin-1 
stabilise an antiparallel β-sheet that increases binding to calcium 
(Downing et  al., 1996; Schrijver et  al., 1999). A cysteine to 
serine substitution is more conservative than a cysteine to 
arginine substitution which introduces a positive charge. These 
factors could account for the differences between these mutations 
both in terms of structural alterations and perturbed interactions 
with binding partners.
In summary, we  have provided the solution structure of 
the N- and C-terminal regions of LTBP4 and shown that 
ARCL1C causing point mutations in the C-terminal region 
result in a more elongated protein with reduced binding to 
tropoelastin, whereas a mutation in the N-terminal region 
induces a more compact conformation and increases binding 
to fibulin-4. Alterations to the interactions between LTBP4 
and tropoelastin and fibulin-4 would likely perturb normal 
elastogenesis contributing to ARCL1C pathogenesis where 
abnormal elastin aggregates are incorrectly incorporated into 
fibrillin microfibril scaffolds. These data also demonstrate the 
importance of the conserved cysteine residues in maintaining 
the structure and function of the LTBP4 terminal regions.
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